Perspectives on Medical Reimbursement By JR Associates In recent months, the coronavirus pandemic (Covid-19) has dramatically disrupted businesses around the world. Arguably, healthcare has been more profoundly affected than any other industry. But even as attention remains focused on virus containment and treatment, medical technology companies must prepare for the long-term. “What next?” is…
Perspectives on Medical Reimbursement By JR Associates The Medical Device Manufacturers Association’s annual Coverage, Reimbursement and Health Policy Conference is always a high point on our firm’s schedule. That’s because our President, Judy Rosenbloom, and our VP of Global Health Policy, Jo Ellen Slurzberg, work hand-in-hand with MDMA each year to develop and deliver this educational event. Our relationship with…
Perspectives on Medical Reimbursement By JR Associates Among our consultants, the MDMA Coverage, Reimbursement and Health Policy Conference is more than just another event on the business calendar. For us, it is an important professional tradition that began 21 years ago. That’s when our President, Judy Rosenbloom, and VP of Global Health Policy, Jo Ellen…
Perspectives on Medical Reimbursement By JR Associates Recently, the trade press and mainstream news have been paying a lot of attention to bundled payments. Stories have focused primarily on how this shift in medical reimbursement will affect patients, providers and payers. Payers and provider networks are creating internal systems to identify the cost of treating…
Perspectives on Medicare Policies By JR Associates SUBJECT: Medicare Physician Fee Schedule Rule: Proposed Changes for the Process for Covering Items and Services in an Investigational Device Exemption (IDE), Centers for Medicare and Medicaid Services (CMS) 78 Fed. Reg. 43282, 43342-47, 43523-25 (July 19, 2013) OVERVIEW: JR Associates is concerned about CMS’ proposed changes to…
New Consultant Position Solidifies Reimbursement Consulting Firm’s Commitment to International Clients Los Angeles, CA — June 30, 2011 — JR Associates, reimbursement advisors to some of the world’s most innovative medical device companies, today announced that Jo Ellen Slurzberg has joined the firm as Vice President, Global Health Policy. With decades of extraordinary reimbursement accomplishments…
Perspectives on Medical Reimbursement By JR Associates Reprinted from The Society of Critical Care Medicine Contributing Authors: Kim Norton* Managing Partner, Argenta Advisors Seattle, Washington, USA Judy Rosenbloom** President, JR Associates Reseda, California, USA George A. Sample, MD*** Washington Hospital Center Washington, D.C. In 2005, the American Heart Association published guidelines (Class IIa and IIb)…
Los Angeles—July 2005—The American Society of Echocardiography (ASE) today announced that JR Associates founder and president, Judy Rosenbloom, has been named Coding and Reimbursement Consultant. On an ongoing basis, Rosenbloom will provide strategic consulting for the ASE membership. A former ASE board member and Advocacy Committee member, Rosenbloom is deeply familiar with ASE’s structure and…
